What is Lynoral (ethinylestradiol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lynoral, containing ethinylestradiol, is a synthetic form of estrogen used primarily as a hormonal contraceptive, but its use should be carefully considered due to potential risks, particularly in smokers over 35, those with high blood pressure, or a history of cardiovascular disease, as highlighted in the most recent guidelines 1.

Overview of Lynoral

Lynoral is a medication that contains ethinylestradiol, a synthetic form of the hormone estrogen. It is used for several purposes, including as a hormonal contraceptive to prevent pregnancy, hormone replacement therapy in women with estrogen deficiency, management of menopausal symptoms, treatment of certain menstrual disorders, and sometimes for hormone therapy in transgender women.

Dosage and Mechanism

The typical dosage of Lynoral ranges from 10-50 micrograms daily, depending on the specific condition being treated. It works by regulating hormone levels in the body, preventing ovulation, thickening cervical mucus to block sperm, and altering the uterine lining to prevent implantation.

Side Effects and Risks

Common side effects of Lynoral may include nausea, headaches, breast tenderness, and changes in menstrual bleeding patterns. However, it's crucial to note that ethinylestradiol-containing medications like Lynoral carry significant risks, including blood clots, stroke, and heart attack, particularly in certain populations such as smokers over 35 years old, those with high blood pressure, or those with a history of cardiovascular disease, as emphasized in recent guidelines 1.

Considerations for Use

Given the potential risks associated with Lynoral, its use should be carefully evaluated, especially in individuals with certain health conditions. For instance, guidelines suggest caution or special monitoring in cases such as breastfeeding (6 weeks-6 months postpartum), age ≥35 years and light smoker (<15 cigarettes per day), and history of hypertension or if monitoring is not feasible 1. The most recent and highest quality study 1 underscores the importance of individualized assessment of benefits and risks for each patient, considering their unique health status and medical history.

Recommendation

Given the potential risks, particularly those related to cardiovascular health, it is recommended that the use of Lynoral be approached with caution, and patients should be thoroughly evaluated by a healthcare provider before starting this medication, with ongoing monitoring as necessary 1. This approach ensures that the benefits of Lynoral are weighed against its potential risks for each individual, aligning with the principles of minimizing morbidity, mortality, and maximizing quality of life.

From the Research

Definition of Lynoral

  • Lynoral is a medicine that contains ethinylestradiol, a synthetic form of estrogen 2, 3, 4.

Uses of Lynoral

  • Lynoral is used as a form of hormonal therapy, often in combination with other hormones such as levonorgestrel 2.
  • It is used to treat conditions such as menopause symptoms, including vasomotor symptoms and genitourinary syndrome of menopause 5.
  • Lynoral is also used as a form of contraception, often in combination with progestogens such as norethisterone 4.

Mechanism of Action

  • Ethinylestradiol, the active ingredient in Lynoral, works by stimulating estrogen receptors in the body 6.
  • It has tissue-specific effects across various organs, including the liver, vascular endothelium, mammary glands, brain, vagina, and uterus 6.

Benefits and Risks

  • Lynoral has been shown to improve insulin resistance, obesity, and glycogen synthase kinase-3 in estrogen-deficient rats 2.
  • However, it also carries risks such as an increased risk of thromboembolism, particularly in women with migraine with aura 3, 4.
  • Long-term use of Lynoral may also be associated with a slightly increased breast cancer risk 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.